Immunoglobulins Market Projected to Grow at a Steady Pace During 2021-2026

The Immunoglobulins Market is segmented by Product (IgG, IgA, IgM, IgE, IgD), Mode of Delivery (Intravenous, Subcutaneous), Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Others) and Region (North America, Europe, Asia-Pacific, and the Rest of the World).

What is immunoglobulin?

Immunoglobulin, also referred to as an antibody, may be a protein synthesized by plasma cells and other lymphocytes. It's a posh entity that exerts its immunomodulatory effect on different components of the system. It's obtained from the blood via the method of fractionation and is purified for therapeutic and non-therapeutic applications.

Key Players

Key players operating in the immunoglobulins market are-

• Baxter international Inc. (US)
• CSL Ltd. (Australia)
• Grifols S.A (Spain)
• Octapharma AG (Switzerland)
• Kedrion Biopharma Inc. (US)
• LFB group (France)
• Biotest AG (Germany)
• China Biologics Products, Inc. (China)
• Shire (Baxalta) (US)
• Bayer Healthcare (Germany).

Market Dynamics

The rise in the geriatric population & the number of hemophilic patients improved immunoglobulin production due to the emergence of advanced technologies, and enhanced purification techniques, with better plasma yield, are some of the key factors bolstering the market growth. Also, the surge in prevalence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia & others is likely to augment the industry growth. However, stringent government regulations about immunoglobulin products and the high risk of side effects due to the usage of immunoglobulin are anticipated to hinder the market growth.

Regional Trends

The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to increasing healthcare expenditure, the growing inclination of clinicians towards immunodeficiency therapies, and the rising level of consciousness for the products involved in the treatment of immunodeficiency disorders. Moreover, beneficial government initiatives and a rise in the number of research partnerships further proliferate regional growth.

Custom Research: Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Article source: https://article-realm.com/article/Finance/37961-Immunoglobulins-Market-Projected-to-Grow-at-a-Steady-Pace-During-2021-2026.html